Thu, December 5, 2024
[ Thu, Dec 05th 2024 ] - MSN
Threads is testing post analytics
[ Thu, Dec 05th 2024 ] - The New York Times
Who Is Tech Really For?
Wed, December 4, 2024
Tue, December 3, 2024
Mon, December 2, 2024
Sun, December 1, 2024
Sat, November 30, 2024
Fri, November 29, 2024
[ Fri, Nov 29th 2024 ] - Tim Hastings
Professor of Rock Engineering

Indian-origin CEO strikes 'significant' UK deal to combat cancer, dementia


//science-technology.news-articles.net/content/2 .. gnificant-uk-deal-to-combat-cancer-dementia.html
Published in Science and Technology on by Tim Hastings   Print publication without navigation

Gordon Sanghera, CEO of Oxford Nanopore Technologies, said the development of a world-first "epigenetic map" of the human genome could lead to breakthroughs in new diagnoses and treatments.

The article from India Today discusses how Harpal Kumar, an Indian-origin CEO of the UK-based charity Cancer Research UK, has facilitated a significant deal with the UK government aimed at combating cancer and dementia. This deal, part of a broader initiative to enhance health research, involves a £100 million investment to accelerate the development of new treatments and diagnostics for these diseases. The agreement seeks to leverage the UK's strengths in life sciences to foster innovation, improve patient outcomes, and potentially save lives by advancing research into early detection and personalized medicine. The initiative also aims to create jobs and stimulate economic growth in the health sector.

Read the Full India Today Article at:
[ https://www.indiatoday.in/world/uk-news/story/indian-origin-ceo-strikes-significant-uk-deal-to-combat-cancer-dementia-2643887-2024-12-02 ]

Publication Contributing Sources